Johan Sundelöf

1.1k total citations
15 papers, 873 citations indexed

About

Johan Sundelöf is a scholar working on Physiology, Psychiatry and Mental health and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Johan Sundelöf has authored 15 papers receiving a total of 873 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 6 papers in Psychiatry and Mental health and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Johan Sundelöf's work include Alzheimer's disease research and treatments (8 papers), Dementia and Cognitive Impairment Research (6 papers) and Palliative Care and End-of-Life Issues (3 papers). Johan Sundelöf is often cited by papers focused on Alzheimer's disease research and treatments (8 papers), Dementia and Cognitive Impairment Research (6 papers) and Palliative Care and End-of-Life Issues (3 papers). Johan Sundelöf collaborates with scholars based in Sweden, United States and United Kingdom. Johan Sundelöf's co-authors include Lars Lannfelt, Malin Degerman-Gunnarsson, Lena Kilander, Johan Sundström, Elina Rönnemaa, Vilmantas Giedraitis, Hans Basun, Björn Zethelius, Christian Berne and Martin Ingelsson and has published in prestigious journals such as PLoS ONE, Neurology and Diabetologia.

In The Last Decade

Johan Sundelöf

14 papers receiving 858 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johan Sundelöf Sweden 13 507 243 183 155 101 15 873
Sabrina A. Capurso Italy 17 499 1.0× 188 0.8× 207 1.1× 154 1.0× 207 2.0× 24 1.1k
Elina Rönnemaa Sweden 11 429 0.8× 234 1.0× 154 0.8× 162 1.0× 93 0.9× 14 850
Elisabeth M. C. Schrijvers Netherlands 10 521 1.0× 420 1.7× 213 1.2× 143 0.9× 107 1.1× 12 1.2k
Louis A. Profenno United States 8 377 0.7× 184 0.8× 146 0.8× 105 0.7× 78 0.8× 11 720
Malin Degerman-Gunnarsson Sweden 11 447 0.9× 130 0.5× 194 1.1× 137 0.9× 40 0.4× 12 714
Alastair Mander Australia 7 510 1.0× 176 0.7× 254 1.4× 247 1.6× 76 0.8× 10 1.1k
Akinori Takeda Japan 18 512 1.0× 221 0.9× 237 1.3× 173 1.1× 36 0.4× 78 1.3k
Chung‐Kai Sun United States 12 608 1.2× 602 2.5× 116 0.6× 178 1.1× 65 0.6× 28 1.1k
Satu Ahtiluoto Finland 11 359 0.7× 313 1.3× 92 0.5× 165 1.1× 187 1.9× 18 953
Karina Braga Gomes Borges Brazil 12 321 0.6× 127 0.5× 178 1.0× 114 0.7× 42 0.4× 19 874

Countries citing papers authored by Johan Sundelöf

Since Specialization
Citations

This map shows the geographic impact of Johan Sundelöf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Sundelöf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Sundelöf more than expected).

Fields of papers citing papers by Johan Sundelöf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Sundelöf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Sundelöf. The network helps show where Johan Sundelöf may publish in the future.

Co-authorship network of co-authors of Johan Sundelöf

This figure shows the co-authorship network connecting the top 25 collaborators of Johan Sundelöf. A scholar is included among the top collaborators of Johan Sundelöf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan Sundelöf. Johan Sundelöf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Melin‐Johansson, Christina, Tove Godskesen, Carina Lundh Hagelin, et al.. (2025). Interdisciplinary strategies for establishing a trusting relation as a pre-requisite for existential conversations in palliative care: a grounded theory study. BMC Palliative Care. 24(1). 47–47. 2 indexed citations
2.
Martinsson, Lisa, Staffan Lundström, & Johan Sundelöf. (2020). Better quality of end-of-life care for persons with advanced dementia in nursing homes compared to hospitals: a Swedish national register study. BMC Palliative Care. 19(1). 135–135. 18 indexed citations
3.
Martinsson, Lisa, Staffan Lundström, & Johan Sundelöf. (2018). Quality of end-of-life care in patients with dementia compared to patients with cancer: A population-based register study. PLoS ONE. 13(7). e0201051–e0201051. 42 indexed citations
4.
Sundelöf, Johan, Johan Sundström, Oskar Hansson, et al.. (2011). Higher Cathepsin B Levels in Plasma in Alzheimer's Disease Compared to Healthy Controls. Journal of Alzheimer s Disease. 22(4). 1223–1230. 77 indexed citations
5.
Wiberg, Britt, et al.. (2010). Cognitive function and risk of stroke in elderly men. Neurology. 74(5). 379–385. 37 indexed citations
6.
Sundelöf, Johan, Johan Sundström, Oskar Hansson, et al.. (2010). Cystatin C Levels are Positively Correlated with both Aβ42 and Tau Levels in Cerebrospinal Fluid in Persons with Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Controls. Journal of Alzheimer s Disease. 21(2). 471–478. 27 indexed citations
7.
Giedraitis, Vilmantas, Lena Kilander, Malin Degerman-Gunnarsson, et al.. (2009). Genetic Analysis of Alzheimer’s Disease in the Uppsala Longitudinal Study of Adult Men. Dementia and Geriatric Cognitive Disorders. 27(1). 59–68. 70 indexed citations
8.
Sundelöf, Johan, Lena Kilander, Johanna Helmersson, et al.. (2009). Systemic Tocopherols and F2-Isoprostanes and the Risk of Alzheimer's Disease and Dementia: A Prospective Population-Based Study. Journal of Alzheimer s Disease. 18(1). 71–78. 16 indexed citations
9.
Rönnemaa, Elina, Björn Zethelius, Johan Sundelöf, et al.. (2009). Glucose metabolism and the risk of Alzheimer’s disease and dementia: a population-based 12 year follow-up study in 71-year-old men. Diabetologia. 52(8). 1504–1510. 50 indexed citations
10.
Sundelöf, Johan, Lena Kilander, Johanna Helmersson, et al.. (2009). Systemic Inflammation and the Risk of Alzheimer's Disease and Dementia: A Prospective Population-Based Study. Journal of Alzheimer s Disease. 18(1). 79–87. 75 indexed citations
11.
Sundelöf, Johan, Vilmantas Giedraitis, Michael C. Irizarry, et al.. (2008). Plasma β Amyloid and the Risk of Alzheimer Disease and Dementia in Elderly Men. Archives of Neurology. 65(2). 256–63. 98 indexed citations
12.
Sundelöf, Johan, Erik Ingelsson, Johan Sundström, et al.. (2008). Serum cystatin C and the risk of Alzheimer disease in elderly men. Neurology. 71(14). 1072–1079. 81 indexed citations
13.
Sundelöf, Johan, Johan Ärnlöv, Erik Ingelsson, et al.. (2008). P4‐108: Serum cystatin C and the risk of Alzheimer's disease. Alzheimer s & Dementia. 4(4S_Part_22).
14.
Rönnemaa, Elina, Björn Zethelius, Johan Sundelöf, et al.. (2008). Impaired insulin secretion increases the risk of Alzheimer disease. Neurology. 71(14). 1065–1071. 183 indexed citations
15.
Giedraitis, Vilmantas, Johan Sundelöf, Michael C. Irizarry, et al.. (2007). The normal equilibrium between CSF and plasma amyloid beta levels is disrupted in Alzheimer's disease. Neuroscience Letters. 427(3). 127–131. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026